Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Theta-burst stimulation (TBS) represents a brain stimulation technique effective for treatment-resistant depression (TRD) as underlined by meta-analyses. While the methodology undergoes constant refinement, bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) appears promising to restore left DLPFC hypoactivity and right hyperactivity found in depression. The post-synaptic inhibitory serotonin-1A (5-HT) receptor, also occurring in the DLPFC, might be involved in this mechanism of action. To test this hypothesis, we performed PET-imaging using the tracer [carbonyl-C]WAY-100635 including arterial blood sampling before and after a three-week treatment with TBS in 11 TRD patients compared to sham stimulation (n = 8 and n = 3, respectively). Treatment groups were randomly assigned, and TBS protocol consisted of excitatory intermittent TBS to the left and inhibitory continuous TBS to the right DLPFC. A linear mixed model including group, hemisphere, time, and Hamilton Rating Scale for Depression (HAMD) score revealed a 3-way interaction effect of group, time, and HAMD on specific distribution volume (V) of 5-HT receptor. While post-hoc comparisons showed no significant changes of 5-HT receptor V in either group, higher 5-HT receptor V after treatment correlated with greater difference in HAMD (r = -0.62). The results of this proof-of-concept trial hint towards potential effects of TBS on the distribution of the 5-HT receptor. Due to the small sample size, all results must, however, be regarded with caution.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892572PMC
http://dx.doi.org/10.1038/s41398-023-02319-3DOI Listing

Publication Analysis

Top Keywords

5-ht receptor
20
theta-burst stimulation
8
dorsolateral prefrontal
8
prefrontal cortex
8
treatment-resistant depression
8
proof-of-concept trial
8
5-ht
6
tbs
6
stimulation
5
receptor
5

Similar Publications

Preclinical models are essential for understanding the pathophysiology of intermittent explosive disorder (IED) in rodents. However, current models fail to fully uncover the molecular mechanisms behind restraint stress-induced aggression. We introduced a restrainer combined with a biting rod to measure IED-associated symptoms in stressed rats.

View Article and Find Full Text PDF

Panic Disorder (PD) is a prevalent psychiatric condition characterized by recurrent episodes of acute severe anxiety. These episodes frequently present with symptoms that overlap with those of cardiovascular diseases (CVD), such as elevated blood pressure and chest pain. Despite the prevalence and impact of this comorbidity, the underlying mechanisms are not well understood and remain underexplored.

View Article and Find Full Text PDF

Key Elements Involved in Alzheimer's Disease Progression.

Cent Nerv Syst Agents Med Chem

September 2025

Department of Biochemistry and Biotechnology, University of Gujrat, Gujrat, Pakistan.

Alzheimer's disease (AD) is a neurodegenerative disease associated with memory loss and a decline in cognitive behavior. It is a progressive brain disorder where an individual's intelligence and reasoning capabilities are highly affected. The ability to think and process any idea is impaired, which is quite common in elders aged above 60 years.

View Article and Find Full Text PDF

Obsessive-compulsive disorder (OCD) is a chronic and debilitating psychiatric condition characterized by persistent, intrusive thoughts (obsessions) and repetitive ritualistic behaviors (compulsions). Accumulating evidence suggests that individuals with OCD demonstrate marked cognitive impairments, especially in executive function domains, including cognitive flexibility and working memory. Although existing therapeutic approaches (e.

View Article and Find Full Text PDF

Despite effective antiretroviral therapy (ART), people with HIV (PWH) experience persistent inflammation and metabolic dysfunction, increasing their risk for non-AIDS comorbidities. Accordingly, we evaluated the effects of long-term/low-dose Δ-tetrahydrocannabinol (THC) supplementation in simian immunodeficiency virus (SIV)-infected, ART-treated rhesus macaques (RMs). THC significantly increased plasma/jejunum serotonin and indole-3-propionate, enhancing gut-brain communication through up-regulation of serotonin receptors (HTR4/HTR7) and aryl hydrocarbon receptor (Ahr) signaling via a cannabinoid receptor (CBR)-2-mediated mechanism.

View Article and Find Full Text PDF